Absence of tissue factor expression by neoplastic plasma cells in multiple myeloma

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

(2011) Antonio Palumbo et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma

(2011) W-J Chng et al.   LEUKEMIA

Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma

(2010) J. J. A. Auwerda et al.   THROMBOSIS AND HAEMOSTASIS

A possible link between Trousseau's syndrome and tissue factor producing plasma cells

(2009) Kazuyuki Shimizu et al.   AMERICAN JOURNAL OF HEMATOLOGY

Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia

(2009) R. Pal et al.   BLOOD

Genetic Link Between Cancer and Thrombosis

(2009) Carla Boccaccio et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of Tissue Factor in Cancer

(2009) Raj S. Kasthuri et al.   JOURNAL OF CLINICAL ONCOLOGY

Venous Thromboembolism in the Hematologic Malignancies

(2009) Anna Falanga et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival Effect of Venous Thromboembolism in Patients With Multiple Myeloma Treated With Lenalidomide and High-Dose Dexamethasone

(2009) Maurizio Zangari et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens

(2008) Adriana M.W. van Marion et al.   LEUKEMIA RESEARCH

Tissue Factor–Bearing Microparticles and Cancer

(2008) Jeffrey Zwicker   SEMINARS IN THROMBOSIS AND HEMOSTASIS